Syndax Pharmaceuticals Inc - COM (SNDX)

Historical Portfolio Holders from Q1 2016 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
88.3 M
Holdings value Q1 2024
$2.1 B
Value change Q1 2024
+$41.1 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
181
Number of buys Q1 2024
109
Number of sells Q1 2024
-68
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.001%
CUSIP
87164F105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 88.3 M $2.1 B +$41.1 M $23.80 182
2023 Q4 86.8 M $1.88 B +$382 M $21.61 175
2023 Q3 70.9 M $1.03 B -$1.57 M $14.52 173
2023 Q2 70.3 M $1.47 B -$31.6 M $20.93 161
2023 Q1 72.8 M $1.54 B +$25.3 M $21.12 159
2022 Q4 71.3 M $1.81 B +$263 M $25.45 153
2022 Q3 59.3 M $1.42 B +$97.8 M $24.03 128
2022 Q2 54.4 M $1.05 B +$14.5 M $19.24 111
2022 Q1 54.3 M $944 M +$26 M $17.38 131
2021 Q4 52.2 M $1.14 B +$54.3 M $21.89 127
2021 Q3 48.9 M $935 M -$21.2 M $19.11 120
2021 Q2 50 M $859 M +$11.9 M $17.17 112
2021 Q1 48.5 M $1.08 B +$47.1 M $22.36 130
2020 Q4 46.3 M $1.03 B +$270 M $22.24 139
2020 Q3 34.2 M $505 M +$23.5 M $14.76 96
2020 Q2 32.3 M $478 M +$173 M $14.82 94
2020 Q1 20.7 M $227 M +$45.3 M $10.97 78
2019 Q4 14.5 M $127 M -$3.74 M $8.78 67
2019 Q3 14.9 M $112 M -$713 K $7.47 67
2019 Q2 14.9 M $139 M +$4.61 M $9.31 67
2019 Q1 17 M $89 M +$8.08 M $5.25 65
2018 Q4 15.4 M $68.6 M -$2.85 M $4.45 70
2018 Q3 15.3 M $124 M +$3.41 M $8.08 69
2018 Q2 15.1 M $106 M -$23.3 M $7.02 80
2018 Q1 17.2 M $244 M +$5.21 M $14.23 72
2017 Q4 16 M $140 M +$23 M $8.76 75
2017 Q3 15 M $176 M -$8.28 M $11.70 67
2017 Q2 15.7 M $219 M +$56.8 M $13.97 63
2017 Q1 11.7 M $160 M +$30.2 M $13.72 62
2016 Q4 11.1 M $79.7 M -$4.87 M $7.17 53
2016 Q3 11.6 M $176 M +$19.9 M $15.16 44
2016 Q2 10.3 M $101 M +$10.8 M $9.85 46
2016 Q1 9.44 M $126 M +$126 M $13.32 26